Fundraising FoxLongwood Fund — 2019 Investments
3 investments dated 2019 · listed companies and verified rows first · show all
Pyxis Oncology develops antibody-drug conjugates and immunotherapies targeting difficult-to-treat cancers to improve patient outcomes.
BiotechDigital HealthHealthtechMedical DevicesBoston, US
Thomas Civik(Interim Chief Executive Officer, Director)
BoardGeeta Vemuri(Director)inJak Knowles(Director)John Flavin(Director)
Board seatDavid SteinbergChristoph Westphal· per SEC Form D
Co-investorsAgent CapitalLifeSci Venture PartnersPfizer Venture InvestmentsRA CapitalTrans-Pacific Technology FundRTW Investments L.P.
A company focused on developing clinical treatments aimed at improving patient outcomes.
BiotechHealthtechMedical DevicesBoston, US
David Southwell(Executive Officer, Director)inRobert Crane(Executive Officer)
BoardSteve Kraus(Director)inCampbell Murray(Director)inHannes Smarason(Director)in
Board seatChristoph WestphalChristoph WestphalLea Hachigian· per SEC Form D
Co-investorsAstellas Venture Management LLCBessemer Venture PartnersGV (Google Ventures)RA Capital6 Dimensions CapitalPitango
HealthtechBoulder, US
Jason Myers(Executive Officer, Director)Christian LaPointe(Executive Officer)
BoardKyle Lefkoff(Director)inPaul Manning(Director)in
Co-investorsCrawley VenturesBoulder VenturesPBM CapitalREDMILESands Capital VenturesSoleus Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.